Matteo Lazzeroni

2.6k total citations
86 papers, 1.5k citations indexed

About

Matteo Lazzeroni is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Matteo Lazzeroni has authored 86 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 38 papers in Cancer Research and 32 papers in Genetics. Recurrent topics in Matteo Lazzeroni's work include Breast Cancer Treatment Studies (28 papers), Estrogen and related hormone effects (26 papers) and Cancer Risks and Factors (17 papers). Matteo Lazzeroni is often cited by papers focused on Breast Cancer Treatment Studies (28 papers), Estrogen and related hormone effects (26 papers) and Cancer Risks and Factors (17 papers). Matteo Lazzeroni collaborates with scholars based in Italy, United States and United Kingdom. Matteo Lazzeroni's co-authors include Bernardo Bonanni, Andrea DeCensi, Davide Serrano, Aliana Guerrieri‐Gonzaga, Giancarlo Pruneri, Sara Gandini, Harriet Johansson, Giuseppe Viale, Massimiliano Cazzaniga and Matteo Puntoni and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Matteo Lazzeroni

79 papers receiving 1.5k citations

Peers

Matteo Lazzeroni

ONCOL

GENET

PFM

Hyun Jo Youn South Korea

Soley Bayraktar United States

Mitsunori Sasa Japan

Sung Hoo Jung South Korea

Mingxin Che United States

Reba Mustafi United States

Abbie Lundgreen United States

Xiaorong Zhong China

Anne C. Deitz United States

Massimiliano Cazzaniga Italy

Hyun Jo Youn South Korea

Matteo Lazzeroni

674 ×1.0

ONCOL

634 ×1.1

503 ×0.9

185 ×0.7

GENET

257 ×1.1

PFM

Citations per year, relative to Matteo Lazzeroni Matteo Lazzeroni (= 1×) peers Hyun Jo Youn

Countries citing papers authored by Matteo Lazzeroni

Since Specialization

Citations

This map shows the geographic impact of Matteo Lazzeroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Lazzeroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Lazzeroni more than expected).

Fields of papers citing papers by Matteo Lazzeroni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Lazzeroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Lazzeroni. The network helps show where Matteo Lazzeroni may publish in the future.

Co-authorship network of co-authors of Matteo Lazzeroni

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Lazzeroni. A scholar is included among the top collaborators of Matteo Lazzeroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Lazzeroni. Matteo Lazzeroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Serrano, Davide, Cristina Zanzottera, Francesca Fava, et al.. (2025). Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies. Genes. 16(1). 82–82. 1 indexed citations

Carbone, Alessio, Martino Oliva, Matteo Puntoni, et al.. (2025). Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase 3 trial in noninvasive breast cancer. JNCI Journal of the National Cancer Institute.

Nicosia, Luca, Luciano Inácio Mariano, Antuono Latronico, et al.. (2024). Exploring non-surgical alternatives for low to intermediate-grade in situ ductal carcinoma of the breast using vacuum-assisted excision: the VACIS protocol. Frontiers in Medicine. 11. 1467738–1467738.

Leonardi, Maria Cristina, Matteo Lazzeroni, Nicola Fusco, et al.. (2024). Tools to Guide Radiation Oncologists in the Management of DCIS. Healthcare. 12(7). 795–795.

Ruscica, Massimiliano, Chiara Macchi, Sara Gandini, et al.. (2024). Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study. Cancers. 16(7). 1411–1411.

Serrano, Davide, et al.. (2023). Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer. Healthcare. 11(16). 2360–2360. 4 indexed citations

Nicosia, Luca, Anna Carla Bozzini, Silvia Penco, et al.. (2022). A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast. Cancers. 14(2). 370–370. 8 indexed citations

Nicosia, Luca, Germana Lissidini, Anna Carla Bozzini, et al.. (2022). Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center. Breast Cancer Research and Treatment. 196(2). 371–377. 6 indexed citations

Lazzeroni, Matteo, Giovanna Petrangolini, Debora Macis, et al.. (2020). Development of an HPLC-MS/MS Method for the Determination of Silybin in Human Plasma, Urine and Breast Tissue. Molecules. 25(12). 2918–2918. 3 indexed citations

10.

Lazzeroni, Matteo, Andrea DeCensi, Aliana Guerrieri‐Gonzaga, et al.. (2020). Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast. Modern Pathology. 33(6). 1065–1077. 5 indexed citations

11.

Johansson, Harriet, Valentina Aristarco, Sara Gandini, et al.. (2019). Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer. The Pharmacogenomics Journal. 20(1). 19–26. 9 indexed citations

12.

Pruneri, Giancarlo, Matteo Lazzeroni, Vincenzo Bagnardi, et al.. (2016). The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast. Annals of Oncology. 28(2). 321–328. 73 indexed citations

13.

DeCensi, Andrea, Matteo Puntoni, Aliana Guerrieri‐Gonzaga, et al.. (2015). Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial. Cancer Prevention Research. 8(10). 888–894. 27 indexed citations

14.

Curigliano, Giuseppe, Davide Disalvatore, Alessandro Esposito, et al.. (2015). Risk of subsequentin situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinomain situ. Annals of Oncology. 26(4). 682–687. 45 indexed citations

15.

Serrano, Davide, Matteo Lazzeroni, & Bernardo Bonanni. (2014). Cancer chemoprevention: Much has been done, but there is still much to do. State of the art and possible new approaches. Molecular Oncology. 9(5). 1008–1017. 25 indexed citations

16.

Gandini, Sara, Aliana Guerrieri‐Gonzaga, Giancarlo Pruneri, et al.. (2013). Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials. Annals of Oncology. 25(3). 618–623. 29 indexed citations

17.

Bonanni, Bernardo, Matteo Puntoni, Massimiliano Cazzaniga, et al.. (2012). Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial. Journal of Clinical Oncology. 30(21). 2593–2600. 195 indexed citations

18.

DeCensi, Andrea, Matteo Puntoni, Giancarlo Pruneri, et al.. (2011). Lapatinib Activity in Premalignant Lesions and HER-2–Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial. Cancer Prevention Research. 4(8). 1181–1189. 48 indexed citations

19.

Serrano, Davide, Matteo Lazzeroni, Carlo‐Federico Zambon, et al.. (2010). Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial. The Pharmacogenomics Journal. 11(2). 100–107. 52 indexed citations

20.

Lazzeroni, Matteo, Aliana Guerrieri‐Gonzaga, Davide Serrano, et al.. (2010). Budesonide versus placebo in high-risk population with screen-detected lung nodules: Rationale, design and methodology. Contemporary Clinical Trials. 31(6). 612–619. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact